AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a number one musculoskeletal options firm, at the moment introduced it’ll proceed its partnership with EUROSPINE as a silver sponsor and can attend EUROSPINE 2023 held October 4 to six in Frankfurt.
“As leaders within the musculoskeletal machine {industry}, we’re dedicated to procedurally built-in innovation that permits surgeons to ship extra clever surgical procedure,” stated Dan Scavilla, chief govt officer at Globus Medical. “Our assist of EUROSPINE displays our perception in partnering with essentially the most influential societies, examine teams, and congresses across the globe to advance spine care and alter the lives of extra sufferers.”
Globus Medical and NuVasive shall be internet hosting varied actions at their respective stands within the Messe Frankfurt exhibition corridor:
- Globus Medical invitations attendees to fulfill the consultants at stand #E35 and study Excelsius™ Susceptible Lateral, ExcelsiusGPS®, and MARVEL™. On October 5 at 12:00, take heed to Dr. David L. Skaggs and Dr. Michele Federico Pecoraro focus on their medical expertise in an {industry} workshop, Robotic Navigation: A dialogue on superior expertise for complicated procedures.
- NuVasive invitations attendees to fulfill the consultants at stand #E45: Simplify Cervical Disc with Prof. Dr. med. Steffen Ok. Rosahl on October 4 at 10:15 and 15:30, Pulse and X360 with Mr. Andrew Younger on October 5 at 10:15 and 15:30, and Reline 3D with Dr. med. Lorenz Wanke-Jellinek on October 6 at 10:15.
Surgeons can even have the chance for demonstrations of procedural options with ExcelsiusGPS on the Globus Medical stand, and Pulse and Siemens Healthineers’ Cios Spin on the NuVasive stand. For extra info, please go to the Globus Medical EUROSPINE webpage and the NuVasive EUROSPINE webpage.
The Firm shall be exhibiting its musculoskeletal procedural options at varied fourth-quarter 2023 conferences, together with:
- Society for Minimally Invasive Backbone Surgical procedure (SMISS) ’23 Annual Discussion board: October 5 to 7 in Las Vegas.
- North American Backbone Society (NASS) 38th Annual Assembly: October 18 to 21 in Los Angeles.
- 17th Worldwide Congress on Early Onset Scoliosis (ICEOS): November 8 to 10 in Charleston.
- German Backbone Congress (DWG) 18th Annual Assembly of the German Backbone Society: November 29 to December 1 in Stuttgart/Ludwigsburg.
- Cervical Backbone Analysis Society (CSRS) 51st Annual Assembly: November 29 to December 2 in Las Vegas.
- 9th Annual Worldwide Spinal Deformity Symposium (ISDS): December 1 to 2 in New York.
- Worldwide Pediatric Orthopedic Symposium (IPOS): December 5 to 9 in Orlando.
About Globus Medical, Inc.
Globus Medical is dedicated to offering progressive applied sciences and industry-leading medical assist to assist surgeons and healthcare suppliers ship higher care across the globe. The Firm supplies one of the complete choices of musculoskeletal options and enabling applied sciences to impression the care continuum, now together with the procedurally built-in portfolio of NuVasive. The Firm’s staff are relentlessly targeted on advancing affected person care. For extra info, please go to www.globusmedical.com/uniting.
Secure Harbor Statements
All statements included on this press launch apart from statements of historic reality are forward-looking statements and could also be recognized by their use of phrases comparable to “imagine,” “could,” “may,” “might,” “will,” “intention,” “estimate,” “proceed,” “anticipate,” “intend,” “anticipate,” “plan” and different related phrases. These forward-looking statements are primarily based on our present assumptions, expectations and estimates of future occasions and developments. Ahead-looking statements are solely predictions and are topic to many dangers, uncertainties and different elements which will have an effect on our companies and operations and will trigger precise outcomes to vary materially from these predicted. These dangers and uncertainties embrace, however should not restricted to, the dangers and prices related to the combination of, and the power of Globus Medical and NuVasive to combine, their companies efficiently and to realize anticipated synergies, well being epidemics, pandemics and related outbreaks, together with the COVID-19 pandemic, elements affecting our quarterly outcomes, our capability to handle our progress, our capability to maintain our profitability, demand for our merchandise, our capability to compete efficiently (together with with out limitation our capability to persuade surgeons to make use of our merchandise and our capability to draw and retain gross sales and different personnel), our capability to quickly develop and introduce new merchandise, our capability to develop and execute on profitable enterprise methods, our capability to adjust to legal guidelines and laws which are or could turn into relevant to our companies, our capability to safeguard our mental property, our success in defending authorized proceedings introduced in opposition to us, developments within the medical machine {industry}, common financial circumstances, and different dangers. For a dialogue of those and different dangers, uncertainties and different elements that would have an effect on our outcomes, it is best to seek advice from the disclosure contained in our most up-to-date annual report on Kind 10-Ok filed with the Securities and Change Fee, together with the sections labeled “Threat Components” and “Cautionary Notice Regarding Ahead-Wanting Statements,” and in our Types 10-Q, Types 8-Ok and different filings with the Securities and Change Fee. These paperwork can be found at www.sec.gov. Furthermore, we function in an evolving setting. New threat elements and uncertainties emerge every so often and it’s not potential for us to foretell all threat elements and uncertainties, nor can we assess the impression of all elements on our enterprise or the extent to which any issue, or mixture of things, could trigger precise outcomes to vary materially from these contained in any forward-looking statements. Given these dangers and uncertainties, readers are cautioned to not place undue reliance on any forward-looking statements. Ahead-looking statements contained on this press launch converse solely as of the date of this press launch. We undertake no obligation to replace any forward-looking statements because of new info, occasions or circumstances or different elements arising or coming to our consideration after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
buyers@globusmedical.com
Media contact:
Melanie Ordoñez
858-722-3899
media@globusmedical.com
Discussion about this post